COX-2 inhibitory treatment in chronic lymphocytic leukemia: a preliminary clinical study.
Kara
Ismail Oguz
IO
Sahin
Berksoy
B
D000368:Aged; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D010865:Pilot Projects; D011720:Pyrazoles; D013449:Sulfonamides / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D009363:Neoplasm Proteins; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib